Komipharm International Co. Ltd (041960) — Working Capital to Net Assets Ratio
Komipharm International Co. Ltd (041960) has a Working Capital to Net Assets ratio of 21.8% as of December 2025. Working capital of ₩15.73 Billion (current assets of ₩68.49 Billion minus current liabilities of ₩52.75 Billion) is measured against net assets of ₩72.06 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Komipharm International Co. Ltd (041960) financial flexibility to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Komipharm International Co. Ltd Working Capital to Net Assets (2014–2025)
This chart shows how Komipharm International Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 21.8%, reflecting working capital of ₩15.73 Billion against net assets of ₩72.06 Billion KRW. See Komipharm International Co. Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Komipharm International Co. Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Komipharm International Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Komipharm International Co. Ltd market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 21.8% | ₩15.73 Billion | ₩72.06 Billion | ₩68.49 Billion | ₩52.75 Billion | ▲ +0.9 pp |
| 2024 | 20.9% | ₩13.70 Billion | ₩65.54 Billion | ₩59.94 Billion | ₩46.23 Billion | ▲ +24.6 pp |
| 2023 | -3.7% | ₩-2.22 Billion | ₩60.02 Billion | ₩50.01 Billion | ₩52.23 Billion | ▼ -6.3 pp |
| 2022 | 2.6% | ₩1.58 Billion | ₩60.63 Billion | ₩42.63 Billion | ₩41.05 Billion | ▼ -21.1 pp |
| 2021 | 23.7% | ₩15.77 Billion | ₩66.46 Billion | ₩41.45 Billion | ₩25.68 Billion | ▲ +16.7 pp |
| 2020 | 7.0% | ₩5.34 Billion | ₩76.28 Billion | ₩44.67 Billion | ₩39.34 Billion | ▼ -14.7 pp |
| 2019 | 21.7% | ₩15.87 Billion | ₩73.28 Billion | ₩46.91 Billion | ₩31.03 Billion | ▲ +10.1 pp |
| 2018 | 11.6% | ₩10.81 Billion | ₩93.39 Billion | ₩48.74 Billion | ₩37.94 Billion | ▼ -5.7 pp |
| 2017 | 17.3% | ₩17.53 Billion | ₩101.27 Billion | ₩53.63 Billion | ₩36.11 Billion | ▲ +0.8 pp |
| 2016 | 16.5% | ₩15.42 Billion | ₩93.20 Billion | ₩52.34 Billion | ₩36.93 Billion | ▼ -5.4 pp |
| 2015 | 21.9% | ₩16.67 Billion | ₩76.13 Billion | ₩43.59 Billion | ₩26.92 Billion | ▲ +13.9 pp |
| 2014 | 8.0% | ₩4.24 Billion | ₩53.16 Billion | ₩42.29 Billion | ₩38.05 Billion | — |